Role of Liquid Chlorophyll As Adjuvant Therapy In Children With Beta Thalassemia

Phase 3

• Conditions: Haematological Disorders; Paediatrics

• Registration Number: PACTR202404706815223
• Lead Sponsor: Faculty of Medicine Tanta University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-16
• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Children with ß- thalassemia aged 1 -18 years

Exclusion Criteria

1.Children with ß- thalassemia who are not compliant with liquid chlorophyll therapy.
2.Children with ß- thalassemia who are allergic to liquid chlorophyll.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
frequency of blood transfusion, CBC parameters, serum ferritin level in both groups

Secondary Outcome Measures

Name	Time	Method
iquid chlorophyll side effects